green tick

Is TAVR being used in the wrong patients?

Is TAVR being used in the wrong patients?

There’s no evidence of its benefit in low and intermediate risk patients, says Aussie surgeon

Get ready for the next heart failure epidemic

Get ready for the next heart failure epidemic

It accounts for about 50% of cases but the only effective treatment appears to be exercise

7 key points from the new acute coronary syndrome guidelines

7 key points from the new acute coronary syndrome guidelines

Rapid and accurate diagnosis is the aim

New guidelines set lower systolic BP target

New guidelines set lower systolic BP target

But even the authors admit to doubts about a more aggressive approach

Heart failure risk warning for 76 drugs

Heart failure risk warning for 76 drugs

American Heart Association provides the most exhaustive guidance yet

view more

Taxing times ahead as sugar falls from favour

Taxing times ahead as sugar falls from favour

The evidence suggests sugar taxes are effective

From genetic heart disease to defibrillators in schools

From genetic heart disease to defibrillators in schools

Professor Christopher Semsarian writes for Cardiology Update in our new series, The Pulse

view more

 Subscribe to the Newsletter

Advertisement
Advertisement
Advertisement
My list
  •  
Read Later